Dr. Fisher is on Doximity
As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
875 blake wilbur drive
Stanford, CA 94305Phone(650) 725-9057
Fax(650) 498-5353- Is this information wrong?
Education & Training
- Stanford UniversityFellowship, Medical Oncology, 1990 - 1993
- Stanford UniversityResidency, Internal Medicine, 1987 - 1989
- Stanford University School of MedicineClass of 1987
Certifications & Licensure
CA State Medical License 1989 - 2023- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- A First-in-Human Phase 1 Dose Escalation Trial of Hu5F9-G4 in Patients With Advanced Solid Malignancies Start of enrollment: 2014 Aug 01Sikic, B.I.
- Phase 2 Study of MK-3475 in Patients With Microsatellite Unstable (MSI) Tumors Start of enrollment: 2013 Sep 01Crocenzi, T.S.,Goldberg, R.M.,Le, D.T.,Fisher, G.
- A Phase II Study of Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors Start of enrollment: 2012 Dec 01Jump, H.M.,Siah, I.,Kunz, P.A.,Kunz, P.
- Exploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma Marko Spasic, MD
Publications & Presentations
PubMed
- A phase I pharmacokinetic and safety study of Paclitaxel Injection Concentrate for Nano-dispersion (PICN) alone and in combination with carboplatin in patients with ad...Wen Wee Ma, Mojun Zhu, Elaine T. Lam, Jennifer R. Diamond, Grace K. Dy, George A. Fisher, Laura W. Goff, Steven R. Alberts, Lynne A. Bui, Akhil Sanghal, Mudgal Kotheka...> ;Cancer Chemotherapy and Pharmacology. 2021 Feb 26
- 2 citationsCD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an ope...Mark H. O'Hara, Eileen M. O'Reilly, Gauri R. Varadhachary, Robert A. Wolff, Zev A. Wainberg, Andrew H. Ko, George A. Fisher, Osama E. Rahma, Jaclyn P. Lyman, Christoph...> ;Lancet Oncology. 2021 Jan 1
- 4 citationsImmune-Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration-Approved Indications ...Satya Das, Kristen Keon Ciombor, Sigurdis Haraldsdottir, Yoanna Pumpalova, Ibrahim Halil Sahin, Gino Pineda, Yu Shyr, Emily Pei Ying Lin, Chih-Yuan Hsu, Shih Kai Chu, ...> ;Oncologist. 2020 Aug 1
- Join now to see all
Lectures
- A phase Ib/II study of the anti-CD47 antibody magrolimab with cetuximab in solid tumor and colorectal cancer patients.ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020
- Using Molecular Diagnostics Across the Cancer Care Continuum to Enhance the Care of Esophageal and Gastric CancerASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
- 9th Annual Meeting of International Society of Gastrointestinal OncologyInternational Society of Gastrointestinal Oncology (ISGIO), Arlington, Virginia - 9/13/2012
Hospital Affiliations
Stanford Health CarePalo Alto, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
